Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).

Date Range:

	Amgen	Gilead Sciences	Biogen	Seattle Genetics	NOVOZYMES A/S/S
Symbol	NASDAQ:AMGN	NASDAQ:GILD	NASDAQ:BIIB	NASDAQ:SGEN	OTCMKTS:NVZMY
Price Information
Current Price	$253.98	$77.81	$282.02	$176.25	$58.48
52 Week Range	Buy	Hold	Hold	Buy	Hold
Beat the Market™ Rank
Overall Score	2.2	2.0	1.7	1.3	0.7
Analysis Score	2.3	2.1	2.1	2.3	0.0
Community Score	3.0	3.3	3.0	2.5	1.8
Dividend Score	3.3	2.5	0.0	0.0	0.8
Ownership Score	1.0	1.0	1.0	1.0	0.0
Earnings & Valuation Score	1.3	1.3	2.5	0.6	0.6
Analyst Ratings
Consensus Recommendation	Buy	Hold	Hold	Buy	Hold
Consensus Price Target	$246.08	$79.65	$307.75	$148.28	N/A
% Upside from Price Target	-3.11% downside	2.37% upside	9.12% upside	-15.87% downside	N/A
Trade Information
Market Cap	$146.50 billion	$97.60 billion	$45.51 billion	$29.98 billion	$17.37 billion
Beta	0.94	0.7	0.54	1.46	0.74
Average Volume	2,654,838	7,775,781	2,093,069	1,066,554	26,360
Sales & Book Value
Annual Revenue	$23.36 billion	$22.45 billion	$14.38 billion	$916.71 million	$2.15 billion
Price / Sales	6.40	4.35	3.20	33.28	8.06
Cashflow	$19.28 per share	$7.44 per share	$39.06 per share	N/A	$1.59 per share
Price / Cash	13.17	10.46	7.22	N/A	36.72
Book Value	$16.28 per share	$17.90 per share	$73.93 per share	$10.95 per share	$5.79 per share
Price / Book	15.60	4.35	3.81	16.10	10.10
Profitability
Net Income	$7.84 billion	$5.39 billion	$5.89 billion	$-158,650,000.00	$472.79 million
EPS	$14.82	$6.14	$33.57	($1.33)	N/A
Trailing P/E Ratio	19.90	20.00	8.70	N/A	0.00
Forward P/E Ratio	15.13	11.60	8.94	N/A	33.61
P/E Growth	$2.13	$3.32	$0.60	N/A	$25.92
Net Margins	32.03%	21.84%	40.76%	-32.81%	22.31%
Return on Equity (ROE)	90.75%	35.44%	49.22%	-16.51%	29.34%
Return on Assets (ROA)	15.44%	12.84%	24.26%	-13.88%	16.10%
Dividend
Annual Payout	$6.40	$2.72	N/A	N/A	$0.52
Dividend Yield	2.52%	3.50%	N/A	N/A	0.89%
Three-Year Dividend Growth	N/A	N/A	N/A	N/A	N/A
Payout Ratio	43.18%	44.30%	N/A	N/A	N/A
Years of Consecutive Dividend Growth	9 Years	4 Years	N/A	N/A	N/A
Debt
Debt-to-Equity Ratio	3.16%	1.00%	0.39%	N/A	0.37%
Current Ratio	1.59%	3.04%	1.73%	4.51%	1.53%
Quick Ratio	1.28%	2.92%	1.54%	4.18%	0.98%
Ownership Information
Institutional Ownership Percentage	75.73%	78.74%	87.34%	94.61%	0.13%
Insider Ownership Percentage	0.36%	0.13%	0.54%	31.10%	N/A
Miscellaneous
Employees	23,400	11,800	7,400	1,605	6,427
Shares Outstanding	588.25 million	1.25 billion	163.19 million	173.10 million	297.00 million
Next Earnings Date	7/28/2020 (Confirmed)	8/4/2020 (Estimated)	7/22/2020 (Confirmed)	7/30/2020 (Confirmed)	8/13/2020 (Estimated)
Optionable	Optionable	Optionable	Optionable	Optionable	Not Optionable

Comparison Ideas:

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Get Started with MarketBeat

	Read Your Daily Newsletter
	Check Out My MarketBeat
	Watch Our Tutorial Videos
	Add a Stock to Your Watchlist
	Set Up an Instant Alert
	View a Company's Profile Page
	View Our Financial Calendars
	View Today's Analyst Ratings

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

Compare Stocks

30 Days of MarketBeat All Access for $1.00

Options Trading from Scratch

Market Data and Calendars

Investing Education and Resources